Affection Animal Pharmaceuticals's last reported valuation, Sep 2022. Nothing priced has surfaced since.
- ·The complete investor list: 12 names
- ·Watch Affection Animal Pharmaceuticals: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Affection Animal Pharmaceuticals funding history
No funding rounds for Affection Animal Pharmaceuticals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Affection Animal Pharmaceuticals valuation
Affection Animal Pharmaceuticals's last reported valuation was $363 million in Sep 2022. No priced round, secondary trade or fund mark has surfaced since.
How Affection Animal Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Affection Animal Pharmaceuticals, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Affection Animal Pharmaceuticals
- What is Affection Animal Pharmaceuticals worth?
- Affection Animal Pharmaceuticals is valued at $363.2M as of Oct 2026. Affection Animal Pharmaceuticals's last reported valuation, Sep 2022. Nothing priced has surfaced since.
- How much has Affection Animal Pharmaceuticals raised?
- Affection Animal Pharmaceuticals has raised $43.7M in total funding across its recorded rounds.